{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:37:39Z","timestamp":1784212659964,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02981-1","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:44:27Z","timestamp":1754631867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Induction of ER stress-mediated apoptosis in breast cancer cell line by the powerful alkylating agent bendamustine and insights into its molecular mechanisms"],"prefix":"10.1007","volume":"42","author":[{"given":"Ganesh","family":"Sankaralingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanimozhi","family":"Subramaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ezhilarasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhamodharan","family":"Umapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remya","family":"Rajan Renuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MukeshKumar Dharmalingam","family":"Jothinathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenbhagaraman","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2981_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2981_CR2","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/JCI60534","volume":"121","author":"K Polyak","year":"2011","unstructured":"Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011;121:3786\u20138.","journal-title":"J Clin Invest"},{"key":"2981_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W-L. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9:92.","journal-title":"Signal Transduct Target Ther"},{"key":"2981_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.semcancer.2019.09.012","volume":"68","author":"S Aggarwal","year":"2021","unstructured":"Aggarwal S, Verma SS, Aggarwal S, Gupta SC. Drug repurposing for breast cancer therapy: old weapon for new battle. Semin Cancer Biol. 2021;68:8\u201320.","journal-title":"Semin Cancer Biol"},{"key":"2981_CR5","doi-asserted-by":"publisher","DOI":"10.3892\/or.2022.8325","author":"H Lalic","year":"2022","unstructured":"Lalic H, Aurer I, Batinic D, Visnjic D, Smoljo T, Babic A. Bendamustine: a review of pharmacology, clinical use and immunological effects (Review). Oncol Rep. 2022. https:\/\/doi.org\/10.3892\/or.2022.8325.","journal-title":"Oncol Rep"},{"key":"2981_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ijc.11679","volume":"109","author":"B Schniewind","year":"2004","unstructured":"Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H, et al. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. Int J Cancer. 2004;109:182\u20138.","journal-title":"Int J Cancer"},{"key":"2981_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1470-2045(15)00447-7","volume":"17","author":"M Rummel","year":"2016","unstructured":"Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, et al. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Lancet Oncol. 2016;17:57\u201366.","journal-title":"Lancet Oncol"},{"key":"2981_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21:71\u201388.","journal-title":"Nat Rev Cancer"},{"key":"2981_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1201\/9781003397755-25","volume-title":"Advanced mammalian cell culture techniques","author":"R Jayasuriya","year":"2023","unstructured":"Jayasuriya R, Amin KN, Mohandas S, Ramkumar KM. Advanced mammalian cell culture techniques. Boca Raton: CRC Press; 2023. p. 80\u20132."},{"key":"2981_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-023-04015-8","volume":"21","author":"F Giordano","year":"2023","unstructured":"Giordano F, Paol\u00ec A, Forastiero M, Marsico S, De Amicis F, Marrelli M, et al. Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner. J Transl Med. 2023;21:165.","journal-title":"J Transl Med"},{"key":"2981_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1201\/9781003397755-26","volume-title":"Advanced mammalian cell culture techniques","author":"R Jayasuriya","year":"2023","unstructured":"Jayasuriya R, Amin KN, Mohandas S, Ramkumar KM. Advanced mammalian cell culture techniques. Boca Raton: CRC Press; 2023. p. 83\u20135."},{"key":"2981_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5:77\u2013106.","journal-title":"Genes Dis"},{"key":"2981_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194779","author":"W Kowalczyk","year":"2021","unstructured":"Kowalczyk W, Waliszczak G, Jach R, Duli\u0144ska-Litewka J. Steroid receptors in breast cancer: understanding of molecular function as a basis for effective therapy development. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13194779.","journal-title":"Cancers"},{"key":"2981_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/14728222.2022.2094762","volume":"26","author":"EM De Francesco","year":"2022","unstructured":"De Francesco EM, Cirillo F, Vella V, Belfiore A, Maggiolini M, Lappano R. Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress. Expert Opin Ther Targets. 2022;26:513\u201335.","journal-title":"Expert Opin Ther Targets"},{"key":"2981_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17111889","author":"D Filioglou","year":"2025","unstructured":"Filioglou D, Santa-Cruz N, Leite GSF, Davini DW, Cracchiolo MJ, Baker FL, et al. A triple oral combination of bendamustine, acalabrutinib, and venetoclax demonstrates efficacy against mantle cell lymphoma in vitro and in vivo. Cancers. 2025. https:\/\/doi.org\/10.3390\/cancers17111889.","journal-title":"Cancers"},{"key":"2981_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0309533","volume":"19","author":"N Osada","year":"2024","unstructured":"Osada N, Kikuchi J, Okada Y, Matsuoka S, Morishita K, Nakasone H, et al. Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells. PLoS ONE. 2024;19:1\u201310.","journal-title":"PLoS ONE"},{"key":"2981_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/00001813-199606000-00007","volume":"7","author":"D Strumberg","year":"1996","unstructured":"Strumberg D, Harstrick A, Doll K, Hoffmann B, Seeber S. Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines. Anticancer Drugs. 1996;7:415\u201321.","journal-title":"Anticancer Drugs"},{"key":"2981_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16183123","author":"CMC Andr\u00e9s","year":"2024","unstructured":"Andr\u00e9s CMC, de P\u00e9rez la Lastra JM, Munguira EB, Andr\u00e9s Juan C, P\u00e9rez-Lebe\u00f1a E. Dual-action therapeutics: DNA alkylation and antimicrobial peptides for cancer therapy. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers16183123.","journal-title":"Cancers"},{"key":"2981_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13050986","author":"NS Aboelella","year":"2021","unstructured":"Aboelella NS, Brandle C, Kim T, Ding Z-C, Zhou G. Oxidative stress in the tumor microenvironment and its relevance to cancer immunotherapy. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13050986.","journal-title":"Cancers"},{"key":"2981_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4027","volume":"42","author":"K Krishnamoorthy","year":"2024","unstructured":"Krishnamoorthy K, Natarajan SR, Veeraraghavan VP, Jayaraman S. Blueberry extract and its bioactive compounds mitigate oxidative stress and suppress human lung cancer cell (A549) growth by modulating the expression of p53\/EGFR\/STAT3\/IL6-mediated signaling molecules. Cell Biochem Funct. 2024;42: e4027.","journal-title":"Cell Biochem Funct"},{"key":"2981_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","volume":"23","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Liu S, Trachootham D, Huang P. Targeting ROS in cancer: rationale and strategies. Nat Rev Drug Discov. 2024;23:583\u2013606.","journal-title":"Nat Rev Drug Discov"},{"key":"2981_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70203","volume":"39","author":"A Sharma","year":"2025","unstructured":"Sharma A, Patel S, Rajput MS. Emerging trends in modulation of transient receptor potential canonical 6 channels as therapeutic targets. J Biochem Mol Toxicol. 2025;39: e70203.","journal-title":"J Biochem Mol Toxicol"},{"key":"2981_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/14728222.2021.1956464","volume":"25","author":"R Singh","year":"2021","unstructured":"Singh R, Adhya P, Sharma SS. Redox-sensitive TRP channels: a promising pharmacological target in chemotherapy-induced peripheral neuropathy. Expert Opin Ther Targets. 2021;25:529\u201345.","journal-title":"Expert Opin Ther Targets"},{"key":"2981_CR24","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1038\/s41598-017-07903-4","volume":"7","author":"S Oda","year":"2017","unstructured":"Oda S, Numaga-Tomita T, Kitajima N, Toyama T, Harada E, Shimauchi T, et al. TRPC6 counteracts TRPC3-Nox2 protein complex leading to attenuation of hyperglycemia-induced heart failure in mice. Sci Rep. 2017;7:7511.","journal-title":"Sci Rep"},{"key":"2981_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101285","volume":"24","author":"NA Hadi","year":"2021","unstructured":"Hadi NA, Mahmood RI, Al-Saffar AZ. Evaluation of antioxidant enzyme activity in doxorubicin treated breast cancer patients in Iraq: a molecular and cytotoxic study. Gene Rep. 2021;24: 101285.","journal-title":"Gene Rep"},{"key":"2981_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/nu15245104","author":"F-F Chiang","year":"2023","unstructured":"Chiang F-F, Huang S-C, Yu P-T, Chao T-H, Huang Y-C. Oxidative stress induced by chemotherapy: evaluation of glutathione and its related antioxidant enzyme dynamics in patients with colorectal cancer. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15245104.","journal-title":"Nutrients"},{"key":"2981_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/480895","volume":"2012","author":"B Poljsak","year":"2012","unstructured":"Poljsak B, Milisav I. The neglected significance of \u201cantioxidative stress.\u201d Oxid Med Cell Longev. 2012;2012: 480895.","journal-title":"Oxid Med Cell Longev"},{"key":"2981_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D\u2019Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8:603\u201319.","journal-title":"Aging"},{"key":"2981_CR29","doi-asserted-by":"publisher","DOI":"10.4103\/jiaomr.jiaomr_119_24","author":"R Deepika","year":"2024","unstructured":"Deepika R, Dharman S, Jayaraman S. Evaluation of Bcl-2, Mcl-1, and Bax as potential biomarkers in chemo radiotherapy induced oral mucositis in head and neck cancer patients: a pilot study. J Indian Acad Oral Med Radiol. 2024. https:\/\/doi.org\/10.4103\/jiaomr.jiaomr_119_24.","journal-title":"J Indian Acad Oral Med Radiol"},{"key":"2981_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4062\/biomolther.2023.149","volume":"32","author":"B DakkakEl","year":"2024","unstructured":"DakkakEl B, Taneera J, El-Huneidi W, Abu-Gharbieh E, Hamoudi R, Semreen MH, et al. Unlocking the therapeutic potential of BCL-2 associated protein family: exploring BCL-2 inhibitors in cancer therapy. Biomol Ther. 2024;32:267\u201380.","journal-title":"Biomol Ther"},{"key":"2981_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.106059","author":"K Balachander","year":"2022","unstructured":"Balachander K, Abilasha R, Priyadharsini JV, Balamurugan R, Paramasivam A. Targeting mitochondria for apoptosis in oral cancer: therapeutic potential and obstacles. Oral Oncol. 2022. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.106059.","journal-title":"Oral Oncol"},{"key":"2981_CR32","first-page":"325","volume":"21","author":"H Azimian","year":"2018","unstructured":"Azimian H, Dayyani M, Toossi MTB, Mahmoudi M. Bax\/Bcl-2 expression ratio in prediction of response to breast cancer radiotherapy. Iran J Basic Med Sci. 2018;21:325\u201332.","journal-title":"Iran J Basic Med Sci"},{"key":"2981_CR33","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1053\/j.seminhematol.2011.03.003","volume":"48","author":"LM Leoni","year":"2011","unstructured":"Leoni LM, Hartley JA. Mechanism of action: the unique pattern of Bendamustine-induced cytotoxicity. Semin Hematol. 2011;48:S12-23.","journal-title":"Semin Hematol"},{"key":"2981_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183680","volume":"12","author":"Y Lei","year":"2017","unstructured":"Lei Y, Wang S, Ren B, Wang J, Chen J, Lu J, et al. CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy. PLoS ONE. 2017;12: e0183680.","journal-title":"PLoS ONE"},{"key":"2981_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174893","volume":"922","author":"MK Prasad","year":"2022","unstructured":"Prasad MK, Mohandas S, Ramkumar KM. Role of ER stress inhibitors in the management of diabetes. Eur J Pharmacol. 2022;922: 174893.","journal-title":"Eur J Pharmacol"},{"key":"2981_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen X, Shi C, He M, Xiong S, Xia X. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal Transduct Target Ther. 2023;8:352.","journal-title":"Signal Transduct Target Ther"},{"key":"2981_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03154","volume":"10","author":"A Li","year":"2019","unstructured":"Li A, Song N-J, Riesenberg BP, Li Z. The emerging roles of endoplasmic reticulum stress in balancing immunity and tolerance in health and diseases: mechanisms and opportunities. Front Immunol. 2019;10: 3154.","journal-title":"Front Immunol"},{"key":"2981_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03083","volume":"9","author":"H Hu","year":"2018","unstructured":"Hu H, Tian M, Ding C, Yu S. The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol. 2018;9: 3083.","journal-title":"Front Immunol"},{"key":"2981_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00109-019-01787-9","volume":"97","author":"O Klymenko","year":"2019","unstructured":"Klymenko O, Huehn M, Wilhelm J, Wasnick R, Shalashova I, Ruppert C, et al. Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells. J Mol Med. 2019;97:973\u201390.","journal-title":"J Mol Med"},{"key":"2981_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11040249","author":"I Dogliotti","year":"2021","unstructured":"Dogliotti I, Ragaini S, Vassallo F, Boccellato E, De Luca G, Perutelli F, et al. Real life use of bendamustine in elderly patients with lymphoid neoplasia. J Pers Med. 2021. https:\/\/doi.org\/10.3390\/jpm11040249.","journal-title":"J Pers Med"},{"key":"2981_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071702","author":"J Stokes","year":"2021","unstructured":"Stokes J, Molina MS, Hoffman EA, Simpson RJ, Katsanis E. Immunomodulatory effects of bendamustine in hematopoietic cell transplantation. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13071702.","journal-title":"Cancers"},{"key":"2981_CR42","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/imj.70037","volume":"55","author":"A Martynchyk","year":"2025","unstructured":"Martynchyk A, Wellard C, Chung E, Bhopal SK, McQuilten ZK, Mulligan SP, et al. Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry report. Intern Med J. 2025;55:937\u201343.","journal-title":"Intern Med J"},{"key":"2981_CR43","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1080\/10428194.2021.1953014","volume":"62","author":"GT Baek","year":"2021","unstructured":"Baek GT, Mathis NJ, Perissinotti AJ, Marini BL, Brown A, Phillips TJ, et al. Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin\u2019s lymphoma. Leuk Lymphoma. 2021;62:3138\u201346.","journal-title":"Leuk Lymphoma"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02981-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02981-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02981-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:27:29Z","timestamp":1757352449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02981-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02981-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"416"}}